Skip to main content
. 2017 Feb 13;8(3):304–311. doi: 10.1007/s13193-017-0620-y

Table 6.

Follow-up of 51 patients

Parameters D1gastrectomy n (%) D2 gastrectomy n (%)
Duration of follow-up(months)
 Mean 11.9 8.9
 Range 2–22 3–21
 Concurrent chemoradiotherapy 25 (75.8) 7 (38.9)
 Adjuvant radiotherapy only 0 (0.0) 2 (11.1)
 Adjuvant chemotherapy only 2 (6.1) 1 (5.6)
 Not fit for chemoradiotherapy 5 (15.2) 1 (5.6)
 Only on follow-up 1 (3.0) 7 (38.9)
Complications during follow-up
 Adhesive intestinal obstruction 1 (3.0 ) 2 (11.1 )
 Diarrhoea 1 (3.0 ) 1 ( 5.6)
Recurrence during follow-up 2 (6.1) 1 (5.6)
Recurrence period
 5 months 0 (0.0) 1 (5.6)
 9 months 1 (3.0) 0 (0.0)
 18 months 1 (3.0) 0 (0.0)
Died during follow-up 11 (33.3) 2 (11.1)
Time of death during follow-up
 3 months 3 (9.1) 0 (0.0)
 6 months 0 (0.0) 2 (11.1)
 9 months 3 (9.1) 0 (0.0)
 12 months 3 (9.1) 0 (0.0)
 22 months 2 (6.1) 0 (0.0)
Total deaths during study period 12 (35.3) 2 (11.1)
Lost follow up 0 0
Total patients followed up 33 (100) 18 (100)